139 related articles for article (PubMed ID: 29418072)
1. Effects of MiR-137 genetic risk score on brain volume and cortical measures in patients with schizophrenia and controls.
Cosgrove D; Mothersill DO; Whitton L; Harold D; Kelly S; Holleran L; Holland J; Anney R; ; Richards A; Mantripragada K; Owen M; O'Donovan MC; Gill M; Corvin A; Morris DW; Donohoe G
Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):369-376. PubMed ID: 29418072
[TBL] [Abstract][Full Text] [Related]
2. Effects of complement gene-set polygenic risk score on brain volume and cortical measures in patients with psychotic disorders and healthy controls.
Holland JF; Cosgrove D; Whitton L; Harold D; Corvin A; Gill M; Mothersill DO; Morris DW; Donohoe G
Am J Med Genet B Neuropsychiatr Genet; 2020 Dec; 183(8):445-453. PubMed ID: 32918526
[TBL] [Abstract][Full Text] [Related]
3. The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis.
Vogel BO; Lett TA; Erk S; Mohnke S; Wackerhagen C; Brandl EJ; Romanczuk-Seiferth N; Otto K; Schweiger JI; Tost H; Nöthen MM; Rietschel M; Degenhardt F; Witt SH; Meyer-Lindenberg A; Heinz A; Walter H
Schizophr Res; 2018 May; 195():190-196. PubMed ID: 28958479
[TBL] [Abstract][Full Text] [Related]
4.
Liu S; Li A; Liu Y; Li J; Wang M; Sun Y; Qin W; Yu C; Jiang T; Liu B
Psychol Med; 2020 Jul; 50(9):1510-1518. PubMed ID: 31239006
[TBL] [Abstract][Full Text] [Related]
5. MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls.
Cosgrove D; Harold D; Mothersill O; Anney R; Hill MJ; Bray NJ; Blokland G; Petryshen T; ; Richards A; Mantripragada K; Owen M; O'Donovan MC; Gill M; Corvin A; Morris DW; Donohoe G
Transl Psychiatry; 2017 Jan; 7(1):e1012. PubMed ID: 28117840
[TBL] [Abstract][Full Text] [Related]
6. Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.
Nicodemus KK; Hargreaves A; Morris D; Anney R; ; ; Gill M; Corvin A; Donohoe G
JAMA Psychiatry; 2014 Jul; 71(7):778-785. PubMed ID: 24828433
[TBL] [Abstract][Full Text] [Related]
7. Schizophrenia risk variants modulate white matter volume across the psychosis spectrum: evidence from two independent cohorts.
Oertel-Knöchel V; Lancaster TM; Knöchel C; Stäblein M; Storchak H; Reinke B; Jurcoane A; Kniep J; Prvulovic D; Mantripragada K; Tansey KE; O'Donovan MC; Owen MJ; Linden DE
Neuroimage Clin; 2015; 7():764-70. PubMed ID: 25844328
[TBL] [Abstract][Full Text] [Related]
8. Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis.
Harrisberger F; Smieskova R; Vogler C; Egli T; Schmidt A; Lenz C; Simon AE; Riecher-Rössler A; Papassotiropoulos A; Borgwardt S
Transl Psychiatry; 2016 Aug; 6(8):e868. PubMed ID: 27505231
[TBL] [Abstract][Full Text] [Related]
9. No effect of schizophrenia risk genes MIR137, TCF4, and ZNF804A on macroscopic brain structure.
Cousijn H; Eissing M; Fernández G; Fisher SE; Franke B; Zwiers M; Harrison PJ; Arias-Vásquez A
Schizophr Res; 2014 Nov; 159(2-3):329-32. PubMed ID: 25217366
[TBL] [Abstract][Full Text] [Related]
10. Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk.
Alnæs D; Kaufmann T; van der Meer D; Córdova-Palomera A; Rokicki J; Moberget T; Bettella F; Agartz I; Barch DM; Bertolino A; Brandt CL; Cervenka S; Djurovic S; Doan NT; Eisenacher S; Fatouros-Bergman H; Flyckt L; Di Giorgio A; Haatveit B; Jönsson EG; Kirsch P; Lund MJ; Meyer-Lindenberg A; Pergola G; Schwarz E; Smeland OB; Quarto T; Zink M; Andreassen OA; Westlye LT;
JAMA Psychiatry; 2019 Jul; 76(7):739-748. PubMed ID: 30969333
[TBL] [Abstract][Full Text] [Related]
11. The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia.
Kuswanto CN; Sum MY; Qiu A; Sitoh YY; Liu J; Sim K
Am J Med Genet B Neuropsychiatr Genet; 2015 Jul; 168B(5):317-26. PubMed ID: 25921703
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia.
Green MJ; Cairns MJ; Wu J; Dragovic M; Jablensky A; Tooney PA; Scott RJ; Carr VJ;
Mol Psychiatry; 2013 Jul; 18(7):774-80. PubMed ID: 22733126
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.
Sakamoto K; Crowley JJ
Am J Med Genet B Neuropsychiatr Genet; 2018 Mar; 177(2):242-256. PubMed ID: 29442441
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia.
Bakken TE; Bloss CS; Roddey JC; Joyner AH; Rimol LM; Djurovic S; Melle I; Sundet K; Agartz I; Andreassen OA; Dale AM; Schork NJ
Arch Gen Psychiatry; 2011 Aug; 68(8):781-90. PubMed ID: 21810643
[TBL] [Abstract][Full Text] [Related]
15. Effect of DISC1 SNPs on brain structure in healthy controls and patients with a history of psychosis.
Kähler AK; Rimol LM; Brown AA; Djurovic S; Hartberg CB; Melle I; Dale AM; Andreassen OA; Agartz I
Am J Med Genet B Neuropsychiatr Genet; 2012 Sep; 159B(6):722-30. PubMed ID: 22815203
[TBL] [Abstract][Full Text] [Related]
16. A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains.
Ranlund S; Calafato S; Thygesen JH; Lin K; Cahn W; Crespo-Facorro B; de Zwarte SMC; Díez Á; Di Forti M; ; Iyegbe C; Jablensky A; Jones R; Hall MH; Kahn R; Kalaydjieva L; Kravariti E; McDonald C; McIntosh AM; McQuillin A; ; Picchioni M; Prata DP; Rujescu D; Schulze K; Shaikh M; Toulopoulou T; van Haren N; van Os J; Vassos E; Walshe M; ; Lewis C; Murray RM; Powell J; Bramon E
Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):21-34. PubMed ID: 28851104
[TBL] [Abstract][Full Text] [Related]
17. The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia.
Lett TA; Chakravarty MM; Felsky D; Brandl EJ; Tiwari AK; Gonçalves VF; Rajji TK; Daskalakis ZJ; Meltzer HY; Lieberman JA; Lerch JP; Mulsant BH; Kennedy JL; Voineskos AN
Mol Psychiatry; 2013 Apr; 18(4):443-50. PubMed ID: 23459466
[TBL] [Abstract][Full Text] [Related]
18. Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working Memory.
Cosgrove D; Mothersill O; Kendall K; Konte B; Harold D; Giegling I; Hartmann A; Richards A; Mantripragada K; ; Owen MJ; O'Donovan MC; Gill M; Rujescu D; Walters J; Corvin A; Morris DW; Donohoe G
Neuropsychopharmacology; 2017 Dec; 42(13):2612-2622. PubMed ID: 28607492
[TBL] [Abstract][Full Text] [Related]
19. A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder.
Duan J; Shi J; Fiorentino A; Leites C; Chen X; Moy W; Chen J; Alexandrov BS; Usheva A; He D; Freda J; O'Brien NL; ; ; McQuillin A; Sanders AR; Gershon ES; DeLisi LE; Bishop AR; Gurling HM; Pato MT; Levinson DF; Kendler KS; Pato CN; Gejman PV
Am J Hum Genet; 2014 Dec; 95(6):744-53. PubMed ID: 25434007
[TBL] [Abstract][Full Text] [Related]
20. Impact on the Onset of Psychosis of a Polygenic Schizophrenia-Related Risk Score and Changes in White Matter Volume.
Harrisberger F; Smieskova R; Egli T; Simon AE; Riecher-Rössler A; Fusar-Poli P; Papassotiropoulos A; Borgwardt S
Cell Physiol Biochem; 2018; 48(3):1201-1214. PubMed ID: 30045020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
